MedDataX Logo

FARAPULSE Workflow Assessment Registry

NCT ID: NCT06656884

Last Updated: 2026-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-06

Study Completion Date

2027-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed to determine the best practices in the patient pathway, and to analyze pre-procedural, procedural and follow-up workflow data related with ablation of atrial fibrillation where the FARAPULSE™ Pulsed Field Ablation System is used in a commercial and standard of care setting. Workflow-related variables, inclusive of pre-procedural imaging, methods of transseptal access, anesthesia/sedation technique, intracardiac mapping, ablation settings, dosing strategy, lesion sets and general procedure management, will be used to identify predominant workflow schemes that will be associated with patient demographics, procedure-related complications (safety parameters), and one-year effectiveness parameters.

The study data can be used for procedural workflow optimization when using Pulsed Field Ablation for the ablation treatment of Atrial Fibrillation based on patient demographics, cardiac anatomy and arrhythmia characteristics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

NCT05501873

Atrial Fibrillation
ACTIVE_NOT_RECRUITING

A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation

NCT06808217

Atrial Fibrillation Pulsed Field Ablation FARAPULSE
RECRUITING

A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF

NCT06335082

Atrial Fibrillation
ENROLLING_BY_INVITATION

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation

NCT05443594

Persistent Atrial Fibrillation
COMPLETED NA

The FARAPULSE FARA-Freedom Trial

NCT05072964

Paroxysmal Atrial Fibrillation
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation (AF)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects are prospectively planned and intended to be treated with the FARAPULSE™ Pulsed Field Ablation system for cardiac tissue ablation, per physician's medical judgement, and as per hospitals' standard of care
* Subjects who are willing and capable of providing informed consent
* Subjects who are willing and capable of participating to this Registry at an approved clinical investigational center
* Subjects whose age is 18 years or above, or who are of legal age to give informed consent specific to state and national law

Exclusion Criteria

* Subjects who are currently enrolled in another investigational study or registry that would directly interfere with the current study. Exceptions are when the subject is participating in a mandatory governmental registry, or a purely observational registry, that do not interfere with the current study
* Prior Left Atrium Ablation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

A.o. Krankenhaus der Elisabethinen Linz

Linz, , Austria

Site Status RECRUITING

Ziekenhuis aan de Stroom, Middelheim

Antwerp, , Belgium

Site Status RECRUITING

Ziekenhuis Oost-Limburg

Genk, , Belgium

Site Status RECRUITING

CHR de la Citadelle

Namur, , Belgium

Site Status RECRUITING

CHU de Bordeaux

Bordeaux, , France

Site Status RECRUITING

Hopital Saint Philibert

Lomme, , France

Site Status RECRUITING

CHRU Hopital Trousseau

Tours, , France

Site Status RECRUITING

Universitaetsklinikum Dusseldorf

Düsseldorf, , Germany

Site Status RECRUITING

Universitaetsklinikum Heidelberg

Heidelberg, , Germany

Site Status WITHDRAWN

Staedtisches Klinikum Karlsruhe

Karlsruhe, , Germany

Site Status RECRUITING

Munchen Klinik Bogenhausen

München, , Germany

Site Status RECRUITING

University Hospital of Muenster

Münster, , Germany

Site Status WITHDRAWN

Ippokrateio General Hospital of Athens

Athens, , Greece

Site Status RECRUITING

Mitera Hospital

Athens, , Greece

Site Status RECRUITING

Azienda Ospedaliero-Universitaria di Ferrara

Ferrara, , Italy

Site Status RECRUITING

Ospedale Dell Angelo

Mestre, , Italy

Site Status RECRUITING

Azienda Ospedaliera San Gerardo

Monza, , Italy

Site Status RECRUITING

Ospedale di Rivoli

Rivoli, , Italy

Site Status RECRUITING

Ospedale San Bortolo di Vicenza Azienda ULSS 8 Berica

Vicenza, , Italy

Site Status RECRUITING

Onze Lieve Vrouwe Gasthuis

Amsterdam, , Netherlands

Site Status WITHDRAWN

King Fahd Armed Forces Hospital

Jeddah, , Saudi Arabia

Site Status RECRUITING

Hospital De La Santa Creu I Sant Pau

Barcelona, , Spain

Site Status RECRUITING

University Hospital Virgen Arrixaca

El Palmar, , Spain

Site Status RECRUITING

Hospital de Navarra

Pamplona, , Spain

Site Status RECRUITING

Hospital Universitario Nuestra Senora de Candelaria

Santa Cruz de Tenerife, , Spain

Site Status RECRUITING

GHP Arytmi Center Stockholm

Stockholm, , Sweden

Site Status RECRUITING

Blackpool Teaching Hospitals NHS Foundation Trust

Blackpool, , United Kingdom

Site Status WITHDRAWN

Royal Bournemouth Hospital

Bournemouth, , United Kingdom

Site Status RECRUITING

Papworth Hospital

Cambridge, , United Kingdom

Site Status RECRUITING

Glenfield Hospital

Leicester, , United Kingdom

Site Status RECRUITING

St. Georges Hospital

London, , United Kingdom

Site Status WITHDRAWN

Freeman Hospital

Newcastle upon Tyne, , United Kingdom

Site Status RECRUITING

Southampton University Hospital

Southampton, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria Belgium France Germany Greece Italy Netherlands Saudi Arabia Spain Sweden United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hanneke Rombouts

Role: CONTACT

[email protected]
0032 480 69 00 65

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Martin Martinek, MD

Role: primary

Michael Wolf

Role: primary

Maximo Rivero, MD

Role: primary

Jean Manuel Herzet, MD

Role: primary

Frederic Sacher, MD

Role: primary

Yves Guyomar, MD

Role: primary

Bertrand Pierre, MD

Role: primary

Obaida Rana, MD

Role: primary

Kerstin Schmidt, MD

Role: primary

Ellen Hoffmann, MD

Role: primary

Konstantinos Tsioufis, MD

Role: primary

Stylianos Tzeis, MD

Role: primary

Matteo Bertini, MD

Role: primary

Sakis Themistoclakis, MD

Role: primary

Giovanni Rovaris, MD

Role: primary

Ruggero Maggio, MD

Role: primary

Antonio Rossillo, MD

Role: primary

Fayez Bokhari, MD

Role: primary

Enrique Rodriguez, MD

Role: primary

Pablo Penafiel, MD

Role: primary

Nuria Basterra, MD

Role: primary

Luis Alvarez-Acosta, MD

Role: primary

Fariborz Tabrizi, MD

Role: primary

Richard Balasubramaniam, MD

Role: primary

Claire Martin, MD

Role: primary

Riyaz Somani, MD

Role: primary

Moloy Das, MD

Role: primary

Waqas Ullah, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PF117

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Feasibility Study of the FARAFLEX Mapping and PFA System
NCT06510556 RECRUITING NA
Concomitant LAAC/AF Ablation (Watchman FLX Pro)
NCT07041125 RECRUITING
Feasibility Study of the FARAPULSE Endocardial Multi Ablation System in the Treatment of Persistent Atrial Fibrillation
NCT04170621 COMPLETED NA
A Single Arm Pilot Study of Pulsed Field Ablation in the Treatment of Paroxysmal Atrial Fibrillation
NCT04474054 COMPLETED NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
NCT06735534 RECRUITING NA
The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
NCT04612244 COMPLETED NA
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
NCT06765356 RECRUITING PHASE4
Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II)
NCT05152966 COMPLETED NA
The Field PULSE Study
NCT06452589 RECRUITING NA
A RWS of the FARAPULSE in A Chinese Population With PAF
NCT05493852 COMPLETED
OPTION-EMEA Clinical Trial
NCT07349121 NOT_YET_RECRUITING NA
FARAPULSE™ Pulsed Field Ablation System
NCT06762717 RECRUITING
Application-Based Integrated Care in Patients After Pulse Field Ablation
NCT07119528 RECRUITING NA
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
NCT06784466 RECRUITING NA
PULSE PVC Registry: Multicenter Study on Focal Pulsed Field Ablation for Premature Ventricular Contractions
NCT07003412 ENROLLING_BY_INVITATION
3-Dimensional Mapping System: The PULSTAR Study
NCT05618340 COMPLETED NA
Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
NCT06801392 RECRUITING
ADVENT Post Approval Study
NCT06431815 ACTIVE_NOT_RECRUITING
IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation
NCT03700385 COMPLETED NA
Primary Anatomical Versus Primary Electrophysiological Approach in Circumferential Pulmonary Vein Ablation
NCT00556595 UNKNOWN NA
Prospective Evaluation of CT Guided Ablation of Cardiac Ganglionated Plexi
NCT04642976 COMPLETED
cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
NCT06686485 RECRUITING
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
NCT06355063 RECRUITING NA
The Added Value of Three-dimensional Electroanatomic Mapping For Accurate Delivery Of Pulsed Field Ablation In The Pulmonary Veins Compared To Pulsed Field Ablation With Fluoroscopy And/Or Intracardiac Echocardiography Alone In The Treatment Of Atrial Fibrillation: MAP-PFA Study
NCT07014423 COMPLETED NA
Local Potential Measurement In PFA: A Pilot Study
NCT06877156 COMPLETED